Experienced in Bile Duct Stricture

Jiahong G. Dong

168 Litang Road, 
Changping, CN 
Experienced in Bile Duct Stricture
168 Litang Road, 
Changping, CN 
OverviewLocationsClinical Research

Overview

Jiahong Dong practices in Changping, China. Dong is rated as an Experienced expert by MediFind in the treatment of Bile Duct Stricture. Their top areas of expertise are Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Hypersplenism, Hepato-Pancreato-Biliary Surgery, and Hepatectomy.

Their clinical research consists of co-authoring 192 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Bile Duct Stricture.

Locations

168 Litang Road, Changping, 102218, China
Other Locations
28 Fuxing Road, Haidian, 100853, China
Lekai South Road 2596, Baoding, 071001, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) as First-line Treatment of Biliary Tract Cancer
A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) as First-line Treatment of Biliary Tract Cancer
Enrollment Status: Terminated
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drugs: Bintrafusp Alfa, Gemcitabine, Cisplatin
Study Phase: Phase 2/Phase 3
Registry Study on the Efficacy of a Self-test and Self-alert Applet in Detecting Susceptible Infection of COVID-19 --a Population Based Mobile Internet Survey
Registry Study on the Efficacy of a Self-test and Self-alert Applet in Detecting Susceptible Infection of COVID-19 --a Population Based Mobile Internet Survey
Enrollment Status: Completed
Publish Date: July 07, 2020
Intervention Type: Other
View 1 Less Clinical Trial

192 Total Publications

Corrigendum to 'Pathology-targeted cell delivery via injectable micro-scaffold capsule mediated by endogenous TGase' [Biomaterials, 126 (2017), 17950].
Corrigendum to 'Pathology-targeted cell delivery via injectable micro-scaffold capsule mediated by endogenous TGase' [Biomaterials, 126 (2017), 17950].
Journal: Biomaterials
Published: July 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dong's expertise for a condition
ConditionClose
      View All 38 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile